These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1247 related items for PubMed ID: 18971536

  • 1. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S, Maki K, Aota Y, Sakuma T, Iwasaka T.
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [Abstract] [Full Text] [Related]

  • 2. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S, Yano Y, Maki K, Iwasaka T.
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM, Schaefer A.
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [Abstract] [Full Text] [Related]

  • 4. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA, Nwose O, Jean-Louis L, Schofield L, Purkayastha D, Baron M.
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [Abstract] [Full Text] [Related]

  • 5. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S.
    Clin Exp Hypertens; 2012 Jun; 34(4):249-57. PubMed ID: 22571446
    [Abstract] [Full Text] [Related]

  • 6. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ, Le Jeune S, Pirollo A, Mourad C, Gaudouen Y, Lopez-Sublet M.
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [Abstract] [Full Text] [Related]

  • 7. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H, Nakamura K, Miura D, Yamanari S, Ohe T.
    Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856
    [Abstract] [Full Text] [Related]

  • 8. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
    Widimský J.
    Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
    [Abstract] [Full Text] [Related]

  • 9. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J, Ansari A, Mahla G, Handrock R, Klebs S.
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [Abstract] [Full Text] [Related]

  • 10. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 11. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S, Yano Y, Maki K, Sawada K.
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [Abstract] [Full Text] [Related]

  • 12. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K, Dohi Y, Nakazawa A, Sugiura T, Yamashita S, Sato K, Kimura G.
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [Abstract] [Full Text] [Related]

  • 13. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 14. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials.
    Waeber B.
    J Hypertens Suppl; 2006 May 25; 24(3):S19-27. PubMed ID: 16723862
    [Abstract] [Full Text] [Related]

  • 15. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
    Lv Y, Zou Z, Chen GM, Jia HX, Zhong J, Fang WW.
    Blood Press Monit; 2010 Aug 25; 15(4):195-204. PubMed ID: 20512032
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J, Hirayama H, Hanasawa T, Watabe D, Asayama K, Metoki H, Kikuya M, Ohkubo T, Totsune K, Imai Y.
    Clin Exp Hypertens; 2005 May 25; 27(4):331-41. PubMed ID: 15921070
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats.
    Choi SM, Seo MJ, Kang KK, Kim JH, Ahn BO, Yoo M.
    Arch Pharm Res; 2009 Mar 25; 32(3):353-8. PubMed ID: 19387578
    [Abstract] [Full Text] [Related]

  • 18. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D, Koç M, Toprak A, Akpinar I, Velioğlu A, Deyneli O, Haklar G, Akalin S.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 25; 4(3):197-203. PubMed ID: 14608527
    [Abstract] [Full Text] [Related]

  • 19. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG, Bakris GL.
    Am J Hypertens; 2004 Jul 25; 17(7):590-6. PubMed ID: 15233978
    [Abstract] [Full Text] [Related]

  • 20. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA, Chang SM, Chou TC.
    J Hum Hypertens; 1995 Aug 25; 9(8):637-41. PubMed ID: 8523379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.